文章摘要
汪飞,胡顺金,王红宇,等.来氟米特和环磷酰胺治疗难治性肾病综合征临床对照研究的Meta分析[J].安徽医药,2018,22(6):1182-1185.
来氟米特和环磷酰胺治疗难治性肾病综合征临床对照研究的Meta分析
Leflunomide and cyclophosphamide in treatment of refractory nephrotic syndrome:A meta-analysis of the efficacy and safety
投稿时间:2016-11-10  
DOI:
中文关键词: 肾病综合征  来氟米特  环磷酰胺  Meta分析(主题)
英文关键词: Nephrotic syndrome  Leflunomide  Cyclophosphamide  Meta-analysis as topic
基金项目:
作者单位
汪飞 安徽省利辛县人民医院肾内科,安徽 亳州 236700 
胡顺金 安徽中医药大学第一附属医院肾病科,安徽 合肥 230031 
王红宇 安徽省利辛县人民医院肾内科,安徽 亳州 236700 
程蔚蔚 安徽省利辛县人民医院肾内科,安徽 亳州 236700 
郑兆国 安徽省利辛县人民医院肾内科,安徽 亳州 236700 
徐雷 安徽省利辛县人民医院肾内科,安徽 亳州 236700 
江晓莉 安徽省利辛县人民医院肾内科,安徽 亳州 236700 
摘要点击次数: 2266
全文下载次数: 544
中文摘要:
      目的 评价来氟米特(LEF)与环磷酰胺(CTX)治疗难治性肾病综合征(RNS)的有效性和安全性。方法 运用Cochrane图书馆(Cochrane Library)、医学检索系统(PUBMED)、医学检索数据库(EMBASE)、中国生物医学文献数据库(CBMdisc)、中国知识基础设施工程(CNKI)、中国科技期刊数据库(VIP)等电子数据库,检索英文、中文检索词检索时间截止至2015年12月30日,由2名评价员对资料进行提取和质量评价,再进行数据分析,数据采用RevMan 5.0软件进行统计。结果 最终纳入10篇文献,共包括511例RNS患者,治疗组261例,对照组250例。Meta分析结果显示,治疗后两组完全缓解率(RR=1.14,95%CI 0.93~1.40,Z=1.23,P=0.22)、部分缓解率(RR=1.04,95%CI 0.84~1.29,Z=0.39,P=0.70)及总缓解率(RR=1.08,95%CI 1.00~1.18,Z=1.91,P=0.06)均差异无统计学意义。6篇文献报道了不良反应发生率,Meta分析结果显示,两组不良反应发生率(RR=0.40,95%CI 0.27~0.58,Z=4.80,P<0.000 01)差异有统计学意义。结论 LEF治疗RNS的有效性与CTX相当,但LEF的安全性优于CTX。但是纳入的文献质量偏差,存在着选择性及测量性偏倚的可能性,需要进一步开展高质量、大样本随机对照试验进行评价。
英文摘要:
      Objective To evaluate the efficacy and safety of Leflunomide (LEF) and Cyclophosphamide (CTX) in treating refractory nephrotic syndrome (RNS).Methods The data of Cochrane library,PUBMED,EMBASE,CBMdisc,CNKI and VIP until 30 December 2015 were retrieved and qualitatively assessed by two systematic reviewers,and RevMan 5.0 software was used to perform statistical analysis.Results A total of 10 literatures were enrolled,including 511 RNS patients (261 in study group,250 in control group).Analysis showed that there was no significant difference between two groups in complete remission rate (RR=1.14,5%CI 0.93-1.40,Z=1.23,P=0.22),partial response rate (RR=1.04,5%CI 0.84-1.29,Z=0.39,P=0.70),and total remission rate (RR=1.08,5%CI 1.00-1.18,Z=1.91,P=0.06).The incidence of adverse reactions was reported in 6 articles.Meta-analysis showed that there was significant difference between two groups in adverse reaction rate (RR=0.40,5%CI 0.27-0.58,Z=4.80,P<0.000 01).Conclusions The effectiveness of LEF in the treatment of RNS is similar to that of CTX,but the safety of LEF is superior to that of CTX.However,due to the bias in the quality of the included literature,there is a possibility of selectivity and measurement bias,so it is necessary to develop the higher quality and larger sample randomized controlled trials to evaluate its effectiveness and safety.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮